GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

15.09.14	Five Prime: Option Exercise By Glaxo For License To Muscle Disease Target (RTTNews)
08.09.14	Gilead: AMBITION Study Of Ambrisentan/Tadalafil Achieves Primary Endpoint (RTTNews)
27.08.14	Ligand's Partner GSK Gets FDA Approval Of SNDA For Promacta/Revolade (RTTNews)
27.08.14	GSK: FDA OKs Promacta SNDA In Patients With Aplastic Anaemia (RTTNews)
20.08.14	GSK Gets FDA Approval For Asthma Drug Arnuity Ellipta (RTTNews)
09.08.14	Foreign Couple Jailed In China For Breaching Privacy Laws (RTTNews)
28.07.14	GSK Has Option To Separate Its Consumer Healthcare Business: FT (RTTNews)
17.07.14	IDMC Recommends GlaxoSmithKline 's Phase III Trial Of MEK/BRAF Combination (RTTNews)
17.07.14	Mylan Says It Wins Motion To Enjoin GSK From Providing Paroxetine CR To Apotex (RTTNews)
07.07.14	GlaxoSmithKline: Anoro Ellipta Gets Approval In Japan For Treatment Of COPD (RTTNews)
04.07.14	GSK And Theravance : Anoro Ellipta Gets Approval In Japan For Treatment Of COPD (RTTNews)
03.07.14	GSK, Genmab Get EC Marketing Authorization For New Indication For Use Of Arzerra (RTTNews)
02.07.14	Isis Pharma Earns $1 Mln From GSK For Advancing Hepatitis B Virus Program (RTTNews)
30.06.14	GSK And Theravance Announce Submission Of SNDA To FDA For FF/VI In Asthma (RTTNews)
24.06.14	Isis Earns Milestone Payment From GlaxoSmithKline Related To ISIS-TTRRx (RTTNews)
13.06.14	Eltrombopag Meets Primary Endpoint In Phase 3 PETIT2 Study - Quick Facts (RTTNews)
12.06.14	ViiV Healthcare, Janssen To Develop Single-tablet Regimen For HIV Patients (RTTNews)
11.06.14	GSK, Theravance Report Positive Data From Two Studies Involving Incruse Ellipta (RTTNews)
05.06.14	GSK To Pay $105 Mln In Multistate Settlement (RTTNews)
28.05.14	Glaxo Faces Investigation By UK's Serious Fraud Office On Commercial Practices (RTTNews)
14.05.14	PERNIX To Buy TREXIMET® Tablets For Migraine From GSK - Quick Facts (RTTNews)
13.05.14	GSK: Darapladib Did Not Meet Primary Endpoint In Second Phase III Study (RTTNews)
01.05.14	GlaxoSmithKline Gets FDA Approval For Umeclidinium In US For Treatment Of COPD (RTTNews)
30.04.14	GlaxoSmithKline Profit Declines - Update (RTTNews)
30.04.14	GSK Q1 Pre-tax Profit Down; Backs 2014 Outlook - Quick Facts (RTTNews)
28.04.14	Glaxo, Theravance Launches Anoro Ellipta In U.S (RTTNews)
22.04.14	GSK,Theravance Announce Phase III Study Of FF/VI In COPD (RTTNews)
22.04.14	Novartis To Exchange Certain Assets With GSK, To Sell Animal Health To Lilly (RTTNews)
22.04.14	Novartis Acquires GSK Oncology Products; Divests Vaccines Business (RTTNews)
17.04.14	GSK, Genmab Get FDA Approval For Arzerra As First-Line Treatment For CLL (RTTNews)
17.04.14	Galapagos: GSK2586184 Meets Primary Endpoint In Phase2a Psoriasis Study (RTTNews)
16.04.14	DVAX Moves On, GSK Gets FDA Nod, HART-Warming, ZGNX Gains On Favorable Ruling (RTTNews)
16.04.14	FDA Approves GSK's Once-weekly Type 2 Diabetes Treatment Tanzeum (RTTNews)
14.04.14	BBC: GSK Faces Bribery Probe In Poland (RTTNews)
04.04.14	WSJ: GlaxoSmithKline Reduces Staff In China Amid Investigation (RTTNews)
02.04.14	GlaxoSmithKline To Stop MAGRIT Trial - Quick Facts (RTTNews)
31.03.14	GSK Presents Data From Pivotal Late-stage STABILITY Study Of Darapladib (RTTNews)
27.03.14	Mylan Wins Lawsuit Against GSK; Jury Awards Mylan $106.7 Mln In Damages (RTTNews)
26.03.14	GSK Withdraws MAA In Europe On Combined Use Of Tafinlar And Mekinist (RTTNews)
20.03.14	GlaxoSmithKline: Phase III Trial Of MAGE-A3 Fails To Meet Co-primary Endpoints (RTTNews)
14.03.14	Glaxo, Theravance Reveal Positive Results From 3 Late-stage Studies In COPD (RTTNews)
10.03.14	GSK Raises Stake In Indian Pharmaceuticals Unit To 75% - Quick Facts (RTTNews)
21.02.14	GlaxoSmithKline: CHMP Issues Positive Opinion On Umeclidinium - Quick Facts (RTTNews)
20.02.14	Anoro Gets Positive CHMP Opinion For COPD Treatment - Quick Facts (RTTNews)
15.02.14	Berkshire Buys 2.95 Mln Liberty Global Shares In Q4, Exits In GSK, Dish (RTTNews)
05.02.14	GlaxoSmithKline Q4 Pre-tax Profit Climbs - Quick Facts (RTTNews)
24.01.14	GSK Gets Positive CHMP Opinion For Eperzan To Treat Type 2 Diabetes (RTTNews)
24.01.14	GSK Reports Results For Late-stage Study Of Combination Of Tafinlar And Mekinist (RTTNews)
21.01.14	ViiV Healthcare: European Commission Approves Tivicay In Treatment Of HIV (RTTNews)
09.01.14	GSK Obtains Accelerated FDA Nod For Combination Use Of Mekinist And Tafinlar (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft